Single-trait and multi-trait genome-wide association analyses identify novel loci for blood pressure in

Jingjing Liang1, Thu H Le2, Digna R Velez Edwards3

  • 1Department of Epidemiology & Biostatistics, School of Medicine, Case Western Reserve University, Cleveland, OH, United States of America.

Plos Genetics
|May 13, 2017
PubMed

Insights

Genetic studies in people of African ancestry identified nine new loci linked to blood pressure and hypertension. These findings highlight specific genetic factors contributing to hypertension risk in this population.

Area of Science:

  • Genetics
  • Cardiovascular Disease
  • Genomics

Background:

  • Hypertension disproportionately affects individuals of African descent, yet they are underrepresented in genetic research.
  • Understanding genetic susceptibility is crucial for addressing health disparities in hypertension.

Purpose of the Study:

  • To identify novel genetic loci associated with blood pressure and hypertension in individuals of African ancestry.
  • To uncover genetic variants contributing to hypertension risk specific to African-ancestry populations.

Main Methods:

  • Conducted single and multiple-trait genome-wide association analyses on 21 studies (31,968 individuals of African ancestry).
  • Validated findings using an additional 54,395 individuals from multi-ethnic cohorts.
  • Performed functional annotation and in vivo experiments (angiotensin-II induced hypertension in mice).

Main Results:

  • Identified nine loci with eleven independent variants reaching genome-wide significance for blood pressure or hypertension.
  • Discovered novel loci (FRMD3) and variants (at FRMD3, GRP20/CDH17, TARID/TCF21, LLPH/TMBIM4) with alleles common in African-ancestry populations.
  • Functional annotation revealed enrichment in immune, kidney, heart, and vascular tissues; mouse experiments showed altered kidney gene expression.

Conclusions:

  • This study provides significant new genetic insights into hypertension susceptibility in people of African ancestry.
  • Highlights the importance of including diverse populations in genetic studies to identify novel biological factors for hypertension.
  • Identified potential therapeutic targets and underscores the need for population-specific genetic research.

Related Concept Videos

Genome-wide Association Studies-GWAS01:11

Genome-wide Association Studies-GWAS

Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
16.0K
Polygenic Traits01:18

Polygenic Traits

When more than one gene is responsible for a given phenotype, the trait is considered polygenic. Human height is a polygenic trait. Studies have uncovered hundreds of loci that influence height, and there are believed to be many more. Due to the high number of genes involved, as well as environmental and nutritional factors, height varies significantly within a given population. The distribution of height forms a bell-shaped curve, with relatively few individuals in the population at the...
69.6K
Factors affecting Blood pressure01:28

Factors affecting Blood pressure

Several physiological and lifestyle factors influence blood pressure (BP). Understanding these factors is crucial as they are significant in patient education and blood pressure management.
Physiological Factors:
7.5K
Pharmacogenomics: Identification of New Drug Targets01:29

Pharmacogenomics: Identification of New Drug Targets

Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
53
Principles of Pharmacogenetics: Types of Genetic Variants01:27

Principles of Pharmacogenetics: Types of Genetic Variants

The human genome is over 99.9% identical between individuals, yet genetic differences exist at millions of bases. The human genome contains approximately 3 million variant positions per individual, many of which are heterozygous, contributing to genetic diversity and individual traits. Genetic variations include single-nucleotide polymorphisms (SNPs), insertions, deletions, and copy number variations (CNVs).SNPs, the most common variation, involve single-base changes in DNA. These can be...
60
Hypertension III: Clinical Manifestations and Diagnostic Studies01:30

Hypertension III: Clinical Manifestations and Diagnostic Studies

Hypertension is asymptomatic and also referred to as the "silent killer" until it progresses to a severe stage or causes target organ disease. Patients may experience symptoms stemming from the strain on blood vessels and tissues in various organs or the heart's increased workload.Physical exams might show no abnormalities other than high blood pressure. Signs of vascular damage, when present, correspond to the organs supplied by the affected vessels, leading to target organ damage. For...
686